Adhesion-Independent Synergy of Monocytes and Endothelial Cells in Cytokine Production: Regulation of IL-6 and GM-CSf Production by Paf

Mediators of Inflammation

Volumn 5, Issue 1, 1996, Pages 56-61

  Turcotte, S ^a   Gingras, D ^a   Rola Pleszczynski, M ^a   Lacasse, C ^b  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b MDS Inc   (Canada)

Author keywords

Endothelial cells; GM CSF; IL 6; Monocytes; PAF; Synergy

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDOMETACIN; INTERLEUKIN 6; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL ADHESION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MONOCYTE; NEWBORN; NORMAL HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0029877761     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/S0962935196000105     Document Type: Article

References (47)

1. Harlan JM. Leukocyte-endothelial interactions. Blood 1985; 65: 513–525.
2. Collins T, Korman AJ, Wake CT, et al. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci USA 1984; 81: 4917–4921.
3. Collins T, Lapierre LA, Fiers W, Strominger JL, Pober JS. Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc Natl Acad Sci USA 1986; 83: 446–450.
4. Bevilacqua MP, Schleef RR, Gimbrone Jr MA, Loskutoff DJ. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. J Clin Invest 1986; 78: 587–591.
5. Camussi G, Aglietta M, Coda R, Bussolino F, Piacibello W, Tetta C. Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. Immunology 1981; 42: 191–199.
6. Camussi G, Aglietta M, Malavasi F, Tetta C, Piacibello W, Sanavio F, Bussolino F. The release of platelet-activating factor from human endothelial cells in culture. J Immunol 1983; 131s 2397–2402.
7. Camussi G, Bussolino F, Tetta C, Piacibello W, Aglietta M. Biosynthesis and release of platelet-activating factor from human monocytes. Int Arch Allergy Appl Immunol 1983; 70: 245–251.
8. Whatley RE, Zimmerman GA, Mclntyre TM, Taylor R, Prescott SM. Production of platelet-activating factor by endothelial cells. Semin Thromb Hemost 1987; 13(4): 445–453.
9. Benveniste J, Henson PM, Cochrane CG. Leukocyte-dependent histamine release from rabbit platelets: the role of IgE, basophils and platelet-activating factor. J Exp Med 1972; 136: 1356–1377.
10. Demopoulos CA, Pinckard RN, Hanahan DJ. Platelet-activating factor. Evidence for l-O-alkyl-2-acetyl-5n-glycero-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem 1979; 254: 9355–9358.
11. Prescott S, Zimmerman GA, Mclntyre TM. Platelet-activating factor. J Biol Chem 1990; 265: 17381–17384.
12. Rola-Pleszczynski M, Pignol B, Pouliot C, Braquet P. Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021. Biochem Biophys Res Commun 1987; 142: 754–760.
13. Rola-Pleszczynski M, Pouliot C, Turcotte S, Pignol B, Braquet P, Bouvrette L. Immune regulation by platelet-activating factor. I. Induction of suppressor cell activity in human monocytes and CD8 + T cells and of helper cell activity in CD4+ T cells. J Immunol 1988; 140: 3547–3552.
14. Poubelle P, Gingras D, Demers C, Dubois C, Harbour D, Rola-Pleszczynski M. Platelet activating factor (PAF-acether) enhances the concomitant production of tumor necrosis factor alpha and interleukin 1 by subsets of human monocytes. Immunology 1991; 72: 181–187.
15. Thivierge M, Rola-Pleszczynski M. Platelet-activating factor (PAF) enhances interleukin-6 production by alveolar macrophages. J Aller Clin Immunol 1992; 90: 796–802.
16. Bussolino F, Camussi G, Aglietta M, et al. Human endothelial cells are targets for platelet-activating factor. I. Platelet-activating factor induces changes in cytoskeleton structures. J Immunol 1987; 139: 2439–2446.
17. Braquet P, Bourgain R, Mencia-Huerta JM. Effect of platelet-activating factor on platelets and vascular endothelium. Sem Thromb Hemos 1989; 15: 184–196.
18. Zimmerman GA, Mclntyre TM, Mehra M, Prescott SM. Endothelial cell-associated platelet-activating factor: a novel mechanism for signalling intercellular adhesion. J Cell Biol 1990; 110: 529–540.
19. Holzinger C, Weissinger E, Zuckermann A, et al. Effects of interleukin-1, -2, -4, -6, interferon-gamma and granulocyte/macrophage colony stimulating factor on human vascular endothelial cells. Immunol Lett 1993; 35: 109–118.
20. Jirik FR, Podor TJ, Hirano T, Kishimoto T, Loskutoff DJ, Carson DA, Lotz M. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol 1989; 142: 144–147.
21. Loppnow H, Libby P. Adult human vascular endothelial cells express the IL-6 gene differentially in response to LPS or IL-1. Cell Immunol 1989; 122: 493–503.
22. Sironi M, Breviario F, Proserpio P, et al. IL-1 stimulates IL-6 production in endothelial cells. J Immunol 1989; 142: 549–553.
23. Bauer J, Ganter U, Geiger T, et al. Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages. Blood 1988; 72: 1134–1140.
24. Tosato G, Seamon KB, Goldman ND, et al. Monocyte-derived human B cell growth factor identified as interferon-β2 (BSF-2, IL-6). Science 1988; 239: 502–504.
25. Navarro S, Debili N, Bernaudin JF, Vainchenker W, Doly J. Regulation of the expression of IL-6 in human monocytes. J Immunol 1989; 142: 4339–4345.
26. Content J, De Wit L, Pierard D, Derynck R, De Clercq E, Fiers W. Secretory proteins induced in human fibroblasts under conditions used for the production of interferon p. Proc Natl Acad Sci USA 1982; 79: 2768–2772.
27. Bagby Jr GC, Dinarello CA, Wallace P, Wagner C, Hefeneider S, McCall E. Interleukin 1 stimulates granulocyte macrophage colony-stimulating activity release by vascular endothelial cells. J Clin Invest 1986; 78: 1316–1323.
28. Broudy VC, Kaushansky K, Harlan JM, Adamson JW. Interleukin 1 stimulates human endothelial cells to produce granulocyte-macrophage colony-simulating factor. J Immunol 1987; 139: 464–468.
29. Segal GM, McCall E, Stueve T, Bagby Jr GC. Interleukin 1 stimulates endothelial cells to release multilineage human colony-stimulating activity. J Immunol 1987; 138: 1772–1778.
30. Sieff CA, Tsai S, Faller DV. Interleukin 1 induces cultured human endothelial cell production of granulocyte-macrophage colony-stimulating factor. J Clin Invest 1987; 79: 48–51.
31. Fibbe WE, Daha MR, Hiemstra PS, et al. Interleukin 1 and poly (rl).poly (rC) induce production of granulocyte CSF, macrophage CSF, and granulocyte-macrophage CSF by human endothelial cells. Exp Hematol 1989; 17: 229–234.
32. Broudy VC, Kaushansky K, Segal GM, Harlan JM, Adamson JW. Tumor necrosis factor type a stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor. Proc Natl Acad Sci USA 1986; 83: 7467–7471.
33. Munker R, Gasson J, Ogawa M, Koeffler HP. Recombinant human TNF induces production of granulocyte-monocyte colony-stimulating factor. Nature 1986; 323: 79–82.
34. Cline MJ, Golde DW. Production of colony-stimulating activity by human lymphocytes. Nature 1974; 248: 703–704.
35. Wodnar-Filipowicz A, Heusser CH, Moroni C. Production of the haemo-poietic growth factors GMCSF and interleukin-3 by mast cells in response to IgE receptor-mediated activation. Nature 1989: 339: 150–152.
36. Thorens B, Mermod JJ, Vassalli P. Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttranscriptional regulation. Cell 1987; 48: 671–679.
37. Gamble JR, Elliott MJ, Jaipargas E, Lopez AF, Vadas MA. Regulation of human monocyte adherence by granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci USA 1989; 86: 7169–7173.
38. Smith PD, Lamerson CL, Wong HL, Wahl LM, Wahl SM. Granulocyte-macrophage colony-stimulating factor stimulates human monocyte accessory cell function. J Immunol 1990; 144: 3829–3834.
39. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745–2756.
40. Moraes JR, Stastny P. A new antigen system expressed in human endothelial cells. J Clin Invest 1977; 60: 449–454.
41. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin lab Invest 1968; 21(suppl. 97): 77–89.
42. Douglas SD, Zuckerman SM, Ackerman SK. Obtaining and culturing human monocytes. In: Adams DO, Edelson PS, Koren M, eds. Methods for Studying Mononuclear Phagocytes. Academic Press, New York, 1981; 33.
43. Lansdorp PM, Aarden LA, Calafat J, Zeiljemaker WP. A growth-factor dependent B-cell hybridoma. Curr Top Microbiol Immunol 1986; 132: 105–113.
44. Aarden LA, DeGroot ER, Schaap OL, Lansdorp PM. Production of hybridomas growth factor by human monocytes. Eur J Immunol 1987; 17: 1411–1416.
45. Heller R, Bussolino F, Ghigo D, Garbarino G, Pescarmona G, Till U, Bosia A. Human endothelial cells are targets for platelet-activating factor. II. Platelet-activating factor induces platelet-activating factor synthesis in human umbilical vein endothelial cells. J Immunol 1992; 149: 3682–3688.
46. Rola-Pleszczynski M, Bouvrette L, Thivierge M, Lacasse C. Platelet-activating factor enhances interleukin 6 production by monocytes, alveolar macrophages and endothelial cells. FASEB J 1990; 4: A1713.
47. 2. J lipid Mediat 1993; 6: 175–181.